Anzalone Christopher Richard bought ARWR

March 4, 2025 · Form 4 insider transaction

Anzalone Christopher Richard bought 133,333 shares of Arrowhead Pharmaceuticals, Inc. at $7.75 per share, a transaction worth $1.03M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.